Bio Details

Gregory Grunberg, MD, MBA

Managing Director, Longitude Capital
Dr. Grunberg has served as a member of our board of directors since April 2016. Dr. Grunberg has been the Managing Director of Longitude Capital Management Co., LLC, or Longitude, since 2012 and has focused on medical technology and drug development. Prior to joining Longitude, Dr. Grunberg was a Principal of Rho Ventures at Rho Capital Partners, Inc. Dr. Grunberg serves as a director of Baronova and California Cryobank, Inc., and has previously served as a director of AqueSys, Inc. and as a Board Observer at SARCode Bioscience Inc., PHT Corporation, Crosstrees Medical, Inc. and Nora Therapeutics, Inc. Dr. Grunberg is also a Lecturer in Medicine at Cornell University and an Attending Faculty member at Albert Einstein University. Dr. Grunberg is Board Certified in Internal Medicine and trained at Cornell’s New York Presbyterian Hospital. He has maintained a limited clinical practice in Internal Medicine and affiliations with University of California, San Francisco, Kaiser, Albert Einstein, U. Miami, Weill-Cornell, and the Weill-Cornell Buganda Medical School in Tanzania. Dr. Grunberg received an M.D. and an M.B.A. from Duke University, where he was a Fuqua Scholar, and an A.B. degree from Amherst College.